# BLUDIGO

NDC: 81284-315
Generic name: indigotindisulfonate sodium
Labeler / Manufacturer: Provepharm Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20220906

FDA application: NDA216264

## Active ingredients

- INDIGOTINDISULFONATE SODIUM: 8 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81284-315"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81284-315
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73f246c4-b127-452e-856f-134b56cb8870